The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites
Abstract
Bacterial translocation appears to be an important mechanism in the pathogenesis of spontaneous infections in cirrhosis. Cirrhotic patients are commonly treated with β-adrenoceptor blockers, but the impact of this treatment in the factors promoting bacterial translocation has not been investigated. This study was aimed at investigating in cirrhotic rats with ascites the effect of propranolol on intestinal bacterial load, transit, and permeability of the bowel and on the rate of bacterial translocation. Bacterial translocation to mesenteric lymph nodes and intestinal bacterial overgrowth, permeability (urinary excretion of 99m Tc-diethylenetriaminepentaacetic acid [99m Tc-DTPA]), and transit (geometric center ratio of 51 Cr) were assessed in 29 rats with carbon tetrachloride (CCl 4) cirrhosis and 20 controls. These variables were then measured in 12 placebo- and in 13 propranolol-treated ascitic cirrhotic rats. Bacterial translocation was present in 48% of the cirrhotic rats and in none of the controls. Cirrhotic rats with intestinal bacterial overgrowth had a significantly higher rate of translocation and slower intestinal transit than those without it. Among the 15 rats with overgrowth and a 99m Tc-DTPA excretion greater than 10%, 15 had translocation and 2 had bacterial peritonitis. Only 1 of the 14 rats with either intestinal overgrowth or a 99m Tc-DTPA excretion greater than 10% presented translocation. Compared with the placebo group, propranolol-treated animals had significantly lower portal pressure, faster intestinal transit, and lower rates of bacterial overgrowth and translocation. In ascitic cirrhotic rats, bacterial translocation results from intestinal overgrowth and severe damage to gut permeability. In this setting, intestinal overgrowth is associated with intestinal hypomotility. Propranolol accelerates the intestinal transit, decreasing the rates of bacterial overgrowth and translocation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accordingly, nonselective β-adrenergic blockers decrease intestinal transit time and reduce intestinal bacterial overgrowth, intestinal permeability and bacterial translocation in experimental models of cirrhosis as well as in patients153–157.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [153]
Citations
Cites
Intestinal permeability: an overview
Bjarnason, I., Macpherson, A., & Hollander, D. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90708-4 · Cited by 927
Ginés, P., Rimola, A., Planas, R., Vargas, V., Marco, F., Almela, M., Forne, M., Miranda, M. L., Llach, J., Salmerón, J. M., et al. (1990) · Hepatology · doi:10.1002/hep.1840120416 · Cited by 627
Increased Intestinal Permeability Associated With Infection in Burn Patients
Ziegler, T. R. (1988) · Archives of Surgery · doi:10.1001/archsurg.1988.01400350027003 · Cited by 316
Accurate measurement of intestinal transit in the rat
Miller, M. S., Galligan, J. J., & Burks, T. F. (1981) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(81)90110-8 · Cited by 288
High Yield Micronodular Cirrhosis in the Rat
Proctor, E., & Chatamra, K. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80126-1 · Cited by 286
Chang, C., Chen, G., Lien, H., & Yeh, H. (1998) · Hepatology · doi:10.1002/hep.510280504 · Cited by 261
Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites
García–Tsao, G., Lee, F., Barden, G. E., Cartun, R. W., & West, A. B. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90147-7 · Cited by 247
Small bowel bacterial overgrowth in patients with alcoholic cirrhosis
Morencos, F. C., Castano, G. D. L. H., Ramos, L. M., Arias, M. J. L., Ledesma, F., & Romero, F. P. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02282340 · Cited by 246
Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites
Guarner, C., Runyon, B. A., Young, S., Heck, M., & Sheikh, M. Y. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80474-6 · Cited by 237
Runyon, B. A., Squier, S. U., & Borzio, M. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80241-6 · Cited by 218
Bacterial Translocation in Acute and Chronic Portal Hypertension
Quigley, E. M. M., & García–Tsao, G. (1994) · Hepatology · doi:10.1002/hep.1840200145 · Cited by 165
Llovet, J. M., Bartolí, R., March, F., Planas, R., Viñado, B., Cabré, E., Arnal, J., Coll, P., Ausina, V., & Gassull, M. A. (1998) · Journal of Hepatology · doi:10.1016/0168-8278(88)80018-7 · Cited by 146
Nitric oxide mediates inhibitory nerve input in human and canine jejunum
Stark, M. E., Bauer, A. J., Sarr, M. G., & Szurszewski, J. H. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90407-4 · Cited by 146
Bacterial translocation in acute and chronic portal hypertension
García–Tsao, G., Albillos, A., Barden, G. E., & West, B. A. (1993) · Hepatology · doi:10.1002/hep.1840170622 · Cited by 141
Self-citationLlovet, J. M., Bartolí, R., Planas, R., Cabré, E., Jiménez, M., Urban, A., Ojanguren, I., Arnal, J., & Gassull, M. À. (1994) · Gut · doi:10.1136/gut.35.11.1648 · Cited by 135
A rodent model of cirrhosis, ascites, and bacterial peritonitis
Runyon, B. A., Sugano, S., Kanel, G. C., & Mellencamp, M. A. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90221-6 · Cited by 133
Albillos, A., Cuervas‐Mons, V., Millán, I., Cantón, T., Montes, J., Barrios, C., Garrido, A., & Escartin, P. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91301-l · Cited by 118
Self-citationINTESTINAL PERMEABILITY AND BACTERIAL TRANSLOCATION FOLLOWING SMALL BOWEL TRANSPLANTATION IN THE RAT
Grant, D. J. W., Hurlbut, D. J., Zhong, R., Wang, P., Chen, H., Garcia, B. M., Behme, R. J., STILLER, C. R., & DUFF, J. (1991) · Transplantation · doi:10.1097/00007890-199108000-00007 · Cited by 81
Llovet, J. M., Bartolí, R., Planas, R., Viñado, B., Perez, J., Cabré, E., Arnal, J., Ojanguren, I., Ausina, V., & Gassull, M. A. (1996) · Hepatology · doi:10.1002/hep.510230419 · Cited by 62
Small intestinal transit in the portal hypertensive rat
Reilly, J. A., Quigley, E. M. M., Forst, C. F., & Rikkers, L. F. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)80010-7 · Cited by 56
Portal venous pressure and portasystemic shunting in experimental portal hypertension
Geraghty, J., Angerson, W. J., & Carter, D. C. (1989) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1989.257.1.g52 · Cited by 52
Gastric emptying and orocecal transit in portal hypertension and end-stage chronic liver disease
Galati, J., Holdeman, K. P., Bottjen, P. L., & Quigley, E. M. M. (1997) · Liver Transplantation and Surgery · doi:10.1002/lt.500030105 · Cited by 38
Modulation of human upper intestinal nutrient transit by a beta adrenoreceptor mediated pathway.
McIntyre, A. S., Thompson, D. G., Day, S. J., Burnham, W. R., & Walker, E. R. C. (1992) · Gut · doi:10.1136/gut.33.8.1062 · Cited by 35
Beta adrenergic modulation of human upper intestinal propulsive forces.
Ahluwalia, N., Thompson, D. G., Barlow, J. D., & Heggie, L. (1994) · Gut · doi:10.1136/gut.35.10.1356 · Cited by 14
Bartolí, R., Pardo, A., Planas, R., Viñado, B., Cabré, E., Rodríguez-Iglesias, M. P., Ausina, V., & Gassull, M. A. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)84906-8 · Cited by 3
Flagged first, then by citations
Cited by
Sorted by citations
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166
Self-citationCirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
Albillos, A., Lario, M., & Álvarez-Mon, M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.010 · Cited by 1,242
Self-citationBacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013
Jalan, R., Fernandez, J., Wiest, R., Schnabl, B., Moreau, R., Angeli, P., Stadlbauer, V., Gustot, T., Bernardi, M., Canton, R., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.024 · Cited by 906
Self-citationPathological bacterial translocation in liver cirrhosis
Wiest, R., Lawson, M. A., & Geuking, M. B. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.044 · Cited by 826
Metadata
- Authors
- Pérez-Paramo, M., Muñoz, J., Albillos, A., Freile, I., Portero, F., Santos, M., & Ortiz-Berrocal, J.
- Venue
- Hepatology
- Published
- 2000-01
- Volume
- 31
- Issue
- 1
- Pages
- 43-48
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2003357282
- Cited by
- 271
- References
- 25
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 12 · 2023: 7 · 2022: 11 · 2021: 5 · 2020: 11 · 2019: 16 · 2018: 13 · 2017: 11 · 2016: 19 · 2015: 13 · 2014: 12 · 2013: 11 · 2012: 16
- FWCI
- 5.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fondo de Investigaciones Sanitarias (99/0356)
- Universidad de Alcalá (E001/98 y E002/99)
- Programa Nacional de Salud from the Comisión Interministerial de Ciencia y Tecnología
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- propranolol, bacterial translocation, liver cirrhosis, ascites, beta-blockers, intestinal bacterial overgrowth, intestinal transit, intestinal permeability, portal hypertension, spontaneous bacterial peritonitis, mesenteric lymph nodes
- MeSH terms
- Animals, Bacteria, Carbon Tetrachloride, Intestinal Absorption, Intestines, Liver Cirrhosis, Experimental, Lymph Nodes, Male, Mesentery, Propranolol, Technetium Tc 99m Pentetate, Rats, Sprague-Dawley, Bacterial Translocation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
